lncRNAs XIST, transcript predicting survival in AKI (TapSAKI), MALAT1, cancer susceptibility candidate 2 (CASC2), and homeobox A cluster antisense RNA 2 (HOXA-AS2) are identified as potential therapeutic targets and predictive biomarkers for AKI.167. This evidence concerns the gene MALAT1 and acute kidney injury.